| Santa Fe Supportive Therapy, Llc | |
|
1418 Luisa St Ste 5a Santa Fe NM 87505-4091 | |
| (505) 926-0906 | |
| (505) 926-0906 |
| Full Name | Santa Fe Supportive Therapy, Llc |
|---|---|
| Speciality | Social Worker |
| Location | 1418 Luisa St Ste 5a, Santa Fe, New Mexico |
| Authorized Official Name and Position | Anika M Kelso (OWNER/PSYCHOTHERAPIST) |
| Authorized Official Contact | 5059260906 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Santa Fe Supportive Therapy, Llc Po Box 6623 Santa Fe NM 87502-6623 Ph: (505) 926-0906 | Santa Fe Supportive Therapy, Llc 1418 Luisa St Ste 5a Santa Fe NM 87505-4091 Ph: (505) 926-0906 |
| NPI Number | 1043502388 |
|---|---|
| Provider Enumeration Date | 05/04/2011 |
| Last Update Date | 01/29/2015 |
| Medicare PECOS PAC ID | 8224439542 |
|---|---|
| Medicare Enrollment ID | O20210624001120 |
News Archive
Scientists have sequenced the genome and characterised the genes of the Asian liver fluke, Opisthorchis viverrini. This parasite causes diseases that affect millions of people in Asia and is associated with a fatal bile duct cancer.
Researchers report that an investigational anti-hypertensive therapy may perform better in controlling blood pressure than standard treatments for patients undergoing heart surgery, during a presentation at the American College of Cardiology's 56th Annual Scientific Session.
AEterna Zentaris Inc. (the "Company"), a global biopharmaceutical company focused on oncology and endocrine therapy, today announced the termination of its agreement with sanofi-aventis U.S. ( SNY) dated March 5, 2009 for the development, commercialization and licensing of cetrorelix in benign prostatic hyperplasia (BPH) for the U.S. market, following the Company's announcement last week of the results for its European Phase 3 study for cetrorelix in BPH.
A new Finnish research reveals how brain's opioids modulate responses towards other people's pain.
› Verified 3 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043502388 | NPI | - | NPPES |
| 70372900 | Medicaid | NM |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | I-06699 (New Mexico) | Primary |
| Provider Name | Carmen Stone |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1831668268 PECOS PAC ID: 3870834757 Enrollment ID: I20190402000939 |
News Archive
Scientists have sequenced the genome and characterised the genes of the Asian liver fluke, Opisthorchis viverrini. This parasite causes diseases that affect millions of people in Asia and is associated with a fatal bile duct cancer.
Researchers report that an investigational anti-hypertensive therapy may perform better in controlling blood pressure than standard treatments for patients undergoing heart surgery, during a presentation at the American College of Cardiology's 56th Annual Scientific Session.
AEterna Zentaris Inc. (the "Company"), a global biopharmaceutical company focused on oncology and endocrine therapy, today announced the termination of its agreement with sanofi-aventis U.S. ( SNY) dated March 5, 2009 for the development, commercialization and licensing of cetrorelix in benign prostatic hyperplasia (BPH) for the U.S. market, following the Company's announcement last week of the results for its European Phase 3 study for cetrorelix in BPH.
A new Finnish research reveals how brain's opioids modulate responses towards other people's pain.
› Verified 3 days ago
| Provider Name | Mary Anne Little |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1386875151 PECOS PAC ID: 0244360725 Enrollment ID: I20210624001508 |
News Archive
Scientists have sequenced the genome and characterised the genes of the Asian liver fluke, Opisthorchis viverrini. This parasite causes diseases that affect millions of people in Asia and is associated with a fatal bile duct cancer.
Researchers report that an investigational anti-hypertensive therapy may perform better in controlling blood pressure than standard treatments for patients undergoing heart surgery, during a presentation at the American College of Cardiology's 56th Annual Scientific Session.
AEterna Zentaris Inc. (the "Company"), a global biopharmaceutical company focused on oncology and endocrine therapy, today announced the termination of its agreement with sanofi-aventis U.S. ( SNY) dated March 5, 2009 for the development, commercialization and licensing of cetrorelix in benign prostatic hyperplasia (BPH) for the U.S. market, following the Company's announcement last week of the results for its European Phase 3 study for cetrorelix in BPH.
A new Finnish research reveals how brain's opioids modulate responses towards other people's pain.
› Verified 3 days ago
| Provider Name | Anika Kelso-lemon |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1699882449 PECOS PAC ID: 9133520455 Enrollment ID: I20210709001592 |
News Archive
Scientists have sequenced the genome and characterised the genes of the Asian liver fluke, Opisthorchis viverrini. This parasite causes diseases that affect millions of people in Asia and is associated with a fatal bile duct cancer.
Researchers report that an investigational anti-hypertensive therapy may perform better in controlling blood pressure than standard treatments for patients undergoing heart surgery, during a presentation at the American College of Cardiology's 56th Annual Scientific Session.
AEterna Zentaris Inc. (the "Company"), a global biopharmaceutical company focused on oncology and endocrine therapy, today announced the termination of its agreement with sanofi-aventis U.S. ( SNY) dated March 5, 2009 for the development, commercialization and licensing of cetrorelix in benign prostatic hyperplasia (BPH) for the U.S. market, following the Company's announcement last week of the results for its European Phase 3 study for cetrorelix in BPH.
A new Finnish research reveals how brain's opioids modulate responses towards other people's pain.
› Verified 3 days ago
| Provider Name | Timothy W Watkins |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1194033100 PECOS PAC ID: 7911357231 Enrollment ID: I20231229000272 |
News Archive
Scientists have sequenced the genome and characterised the genes of the Asian liver fluke, Opisthorchis viverrini. This parasite causes diseases that affect millions of people in Asia and is associated with a fatal bile duct cancer.
Researchers report that an investigational anti-hypertensive therapy may perform better in controlling blood pressure than standard treatments for patients undergoing heart surgery, during a presentation at the American College of Cardiology's 56th Annual Scientific Session.
AEterna Zentaris Inc. (the "Company"), a global biopharmaceutical company focused on oncology and endocrine therapy, today announced the termination of its agreement with sanofi-aventis U.S. ( SNY) dated March 5, 2009 for the development, commercialization and licensing of cetrorelix in benign prostatic hyperplasia (BPH) for the U.S. market, following the Company's announcement last week of the results for its European Phase 3 study for cetrorelix in BPH.
A new Finnish research reveals how brain's opioids modulate responses towards other people's pain.
› Verified 3 days ago
News Archive
Scientists have sequenced the genome and characterised the genes of the Asian liver fluke, Opisthorchis viverrini. This parasite causes diseases that affect millions of people in Asia and is associated with a fatal bile duct cancer.
Researchers report that an investigational anti-hypertensive therapy may perform better in controlling blood pressure than standard treatments for patients undergoing heart surgery, during a presentation at the American College of Cardiology's 56th Annual Scientific Session.
AEterna Zentaris Inc. (the "Company"), a global biopharmaceutical company focused on oncology and endocrine therapy, today announced the termination of its agreement with sanofi-aventis U.S. ( SNY) dated March 5, 2009 for the development, commercialization and licensing of cetrorelix in benign prostatic hyperplasia (BPH) for the U.S. market, following the Company's announcement last week of the results for its European Phase 3 study for cetrorelix in BPH.
A new Finnish research reveals how brain's opioids modulate responses towards other people's pain.
› Verified 3 days ago
Sangre De Cristo Community Health Partnership Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1441 S Saint Francis Dr, Santa Fe, NM 87505 Phone: 505-982-8870 Fax: 505-982-4480 | |
Youth Shelters Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 5686 Agua Fria St, Santa Fe, NM 87507 Phone: 505-438-0502 Fax: 505-438-0504 | |
Carrie T. Ishee Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1519 Upper Canyon Rd, Santa Fe, NM 87501 Phone: 505-670-0686 | |
Vega Diagnostic & Consulting Services, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 29 Rito Guicu, Santa Fe, NM 87507 Phone: 505-235-4002 | |
Youth Shelters Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 5686 Agua Fria St, Santa Fe, NM 87507 Phone: 505-983-0586 Fax: 505-424-0949 | |
Equest Counseling Center Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 17661 Us 84/285, Santa Fe, NM 87506 Phone: 505-455-0555 Fax: 505-455-2237 | |
William Wengs, Md Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 2009 Botulph Rd, Suite 500, Santa Fe, NM 87505 Phone: 505-986-2890 Fax: 505-986-2893 |